comparemela.com

Latest Breaking News On - North american antiepileptic drug - Page 4 : comparemela.com

SK life science Presents Latest Data on XCOPRI® (cenobamate tablets) CV in Adults with Partial-Onset (Focal) Seizures at the AES 2022 Annual Meeting

/PRNewswire/ SK Life Science, Inc., a subsidiary of SK Biopharmaceuticals Co., Ltd., an innovative global pharmaceutical company focused on developing.

United statesUnited kingdomAngelini pharmaPrnewswire sk life science incSk groupSource sk life science incSk biopharmaceuticals co ltdAmerican epilepsy societyEpilepsy foundationSk incSk life science incEuropean unionSudden unexpected deathAnnual meetingResponder rates overOno pharmaceutical

Jazz Pharmaceuticals to Present Data Demonstrating Advancements in Epilepsy Outcomes at the 2022 American Epilepsy Society Annual Meeting

/PRNewswire/ Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that six company-sponsored Epidiolex® (cannabidiol) oral solution presentations,.

United statesCounty south dublinUnited kingdomGreat britainKristin bhavnaniKelvin tanAndrean flynnEpidiolex epidyolexCommission file noEpidiolex caregiver surveyAmerican epilepsy societyJazz pharmaceuticalsArts allianceTuberous sclerosis allianceEuropean unionTs alliance website

EISAI TO PRESENT LATEST DATA ON FYCOMPA® (PERAMPANEL) CIII AT THE 76TH AMERICAN EPILEPSY SOCIETY (AES) ANNUAL MEETING

/PRNewswire/ Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") announced today that the company will have a total of 34 posters, including.

United statesNew zealandHaruo naitoUs drug enforcement administrationPrnewswire eisai co ltdEisai incEisai europe ltdAmerican epilepsy society annual meetingEisai co ltdUnited nations sustainable development goals sdgsEnforcement administrationCorporate conceptUnited nations sustainable development goalsMiddle eastNorth american antiepileptic drugPrescribing information

SK Biopharmaceuticals Named CES 2023 Innovation Awards Honoree

SK Biopharmaceuticals is recognized in the digital health category for two wearable devices – Zero Glasses TM and Zero Wired TM – becoming the fir.

United statesNew jerseyUnited kingdomKyonggi doSouth koreaHyunkyung choAngelini pharmaLas vegasHead of communicationsEuropean unionDrug administrationConsumer technology associationSource sk biopharmaceuticals co ltdDeputy communicationsZero glassesZero wired

SK Biopharmaceuticals Named CES 2023 Innovation Awards Honoree

/PRNewswire/ SK Biopharmaceuticals, an innovative global pharmaceutical company, announced that it has been named a CES® 2023 Innovation Awards Honoree for.

United statesNew jerseyUnited kingdomKyonggi doSouth koreaHyunkyung choAngelini pharmaLas vegasHead of communicationsEuropean unionDrug administrationConsumer technology associationSource sk biopharmaceuticals co ltdDeputy communicationsZero glassesZero wired

vimarsana © 2020. All Rights Reserved.